Close to a cure for type 1 diabetes

Posted by JOrchard on 29 January, 2016

Scientists believe that they are becoming very close to being able to cure Type 1 diabetes, and perhaps making daily insulin shots a thing of the past for patients, according to studies that were published on 24th January.


The latest diabetes news from Dermatonics 

Researchers from top America universities said that they are on the verge of developing replacements for pancreatic cells that are mysteriously destroyed by a patient’s own body - therefore making it impossible for insulin to be created which regulated blood sugar levels in the body.

Daniel Anderson, an MIT chemical engineering professor had this to say “We are excited by these results, and we are working hard to advance this technology to the clinic.”

The Scary Fact - Diabetes 

The number of people who now suffer from diabetes has risen to more than 3 million in the UK and this figure continues to grow by almost 5% every year, a staggering figure that if we were able to cure Type 1 diabetes would definitely fall.

Type 1 diabetes is believed to be a genetic condition, meaning that your lifestyle and health does not have any part to play in the condition.

“Encapsulation therapies have the potential to be groundbreaking for people with (Type 1 diabetes),” said Julia Greenstein, vice president of discovery research of the JDFR, formerly known as the Juvenile Diabetes Research Foundation. “These treatments aim to effectively establish long-term insulin independence and eliminate the daily burden of managing the disease for months, possibly years, at a time without the need for immune suppression”

If you suffer from diabetes, please visit our innovations/products page, we believe that these products can make living with diabetes a little bit easier.

News Archive

This site uses cookies. Some of the cookies we use are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but parts of the site will not work.